| SC 13G/A | 2024-02-14 | PFM Health Sciences, LP | ESSA Pharma Inc. | - | 7.4% | EDGAR |
| SC 13G | 2024-02-14 | RTW INVESTMENTS, LP | ESSA Pharma Inc. | 2,298,662 | 5.2% | EDGAR |
| SC 13G/A | 2024-02-13 | BB BIOTECH AG | ESSA Pharma Inc. | 7,879,583 | 17.9% | EDGAR |
| SC 13G | 2024-02-08 | MORGAN STANLEY | ESSA Pharma Inc. | 4,186,578 | 9.5% | EDGAR |
| SC 13G/A | 2024-01-23 | Soleus Capital, LLC | ESSA Pharma Inc. | 4,327,622 | 9.8% | EDGAR |
| SC 13G/A | 2023-02-14 | RTW INVESTMENTS, LP | ESSA Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-14 | Avidity Partners Management LP | ESSA Pharma Inc. | 1,855,400 | 4.2% | EDGAR |
| SC 13G/A | 2023-02-14 | Soleus Capital, LLC | ESSA Pharma Inc. | 3,869,392 | 8.8% | EDGAR |
| SC 13G/A | 2023-02-14 | PFM Health Sciences, LP | ESSA Pharma Inc. | - | 8.7% | EDGAR |
| SC 13G/A | 2023-02-14 | BB BIOTECH AG | ESSA Pharma Inc. | 7,879,583 | 17.9% | EDGAR |
| SC 13G/A | 2023-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2023-02-09 | JANUS HENDERSON GROUP PLC | ESSA Pharma Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-11-10 | PFM Health Sciences, LP | ESSA Pharma Inc. | - | 8.7% | EDGAR |
| SC 13G | 2022-10-27 | Avidity Partners Management LP | ESSA Pharma Inc. | 3,750,000 | 8.5% | EDGAR |
| SC 13G/A | 2022-07-12 | BIOTECHNOLOGY VALUE FUND L P | ESSA Pharma Inc. | 4,712,590 | 10.7% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | ESSA Pharma Inc. | 2,637,192 | 6.0% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | ESSA Pharma Inc. | 3,055,474 | 6.7% | EDGAR |
| SC 13G/A | 2022-02-14 | EVENTIDE ASSET MANAGEMENT, LLC | ESSA Pharma Inc. | 3,318,647 | 7.5% | EDGAR |
| SC 13G/A | 2022-02-11 | PFIZER INC | ESSA Pharma Inc. | 1,675,000 | 3.8% | EDGAR |
| SC 13G/A | 2022-02-11 | BB BIOTECH AG | ESSA Pharma Inc. | 5,015,814 | 11.4% | EDGAR |